Table of Content

1 Study Coverage
1.1 Platelet-Rich Plasma Injection Product Introduction
1.2 Market by Type
1.2.1 Global Platelet-Rich Plasma Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Leukocyte-rich (LR)-PRP
1.2.3 Leukocyte-poor (LP)-PRP
1.2.4 Others
1.3 Market by Application
1.3.1 Global Platelet-Rich Plasma Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Platelet-Rich Plasma Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Platelet-Rich Plasma Injection Revenue by Region
2.2.1 Global Platelet-Rich Plasma Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Platelet-Rich Plasma Injection Revenue by Region (2018-2024)
2.2.3 Global Platelet-Rich Plasma Injection Revenue by Region (2024-2029)
2.2.4 Global Platelet-Rich Plasma Injection Revenue Market Share by Region (2018-2029)
2.3 Global Platelet-Rich Plasma Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Platelet-Rich Plasma Injection Sales by Region
2.4.1 Global Platelet-Rich Plasma Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Platelet-Rich Plasma Injection Sales by Region (2018-2024)
2.4.3 Global Platelet-Rich Plasma Injection Sales by Region (2024-2029)
2.4.4 Global Platelet-Rich Plasma Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Platelet-Rich Plasma Injection Sales by Manufacturers
3.1.1 Global Platelet-Rich Plasma Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Platelet-Rich Plasma Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Platelet-Rich Plasma Injection in 2022
3.2 Global Platelet-Rich Plasma Injection Revenue by Manufacturers
3.2.1 Global Platelet-Rich Plasma Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Platelet-Rich Plasma Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Platelet-Rich Plasma Injection Revenue in 2022
3.3 Global Key Players of Platelet-Rich Plasma Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Platelet-Rich Plasma Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Platelet-Rich Plasma Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Platelet-Rich Plasma Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Platelet-Rich Plasma Injection, Product Offered and Application
3.8 Global Key Manufacturers of Platelet-Rich Plasma Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Platelet-Rich Plasma Injection Sales by Type
4.1.1 Global Platelet-Rich Plasma Injection Historical Sales by Type (2018-2024)
4.1.2 Global Platelet-Rich Plasma Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
4.2 Global Platelet-Rich Plasma Injection Revenue by Type
4.2.1 Global Platelet-Rich Plasma Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Platelet-Rich Plasma Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
4.3 Global Platelet-Rich Plasma Injection Price by Type
4.3.1 Global Platelet-Rich Plasma Injection Price by Type (2018-2024)
4.3.2 Global Platelet-Rich Plasma Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Platelet-Rich Plasma Injection Sales by Application
5.1.1 Global Platelet-Rich Plasma Injection Historical Sales by Application (2018-2024)
5.1.2 Global Platelet-Rich Plasma Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
5.2 Global Platelet-Rich Plasma Injection Revenue by Application
5.2.1 Global Platelet-Rich Plasma Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Platelet-Rich Plasma Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
5.3 Global Platelet-Rich Plasma Injection Price by Application
5.3.1 Global Platelet-Rich Plasma Injection Price by Application (2018-2024)
5.3.2 Global Platelet-Rich Plasma Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Platelet-Rich Plasma Injection Market Size by Type
6.1.1 US & Canada Platelet-Rich Plasma Injection Sales by Type (2018-2029)
6.1.2 US & Canada Platelet-Rich Plasma Injection Revenue by Type (2018-2029)
6.2 US & Canada Platelet-Rich Plasma Injection Market Size by Application
6.2.1 US & Canada Platelet-Rich Plasma Injection Sales by Application (2018-2029)
6.2.2 US & Canada Platelet-Rich Plasma Injection Revenue by Application (2018-2029)
6.3 US & Canada Platelet-Rich Plasma Injection Market Size by Country
6.3.1 US & Canada Platelet-Rich Plasma Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Platelet-Rich Plasma Injection Sales by Country (2018-2029)
6.3.3 US & Canada Platelet-Rich Plasma Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Platelet-Rich Plasma Injection Market Size by Type
7.1.1 Europe Platelet-Rich Plasma Injection Sales by Type (2018-2029)
7.1.2 Europe Platelet-Rich Plasma Injection Revenue by Type (2018-2029)
7.2 Europe Platelet-Rich Plasma Injection Market Size by Application
7.2.1 Europe Platelet-Rich Plasma Injection Sales by Application (2018-2029)
7.2.2 Europe Platelet-Rich Plasma Injection Revenue by Application (2018-2029)
7.3 Europe Platelet-Rich Plasma Injection Market Size by Country
7.3.1 Europe Platelet-Rich Plasma Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Platelet-Rich Plasma Injection Sales by Country (2018-2029)
7.3.3 Europe Platelet-Rich Plasma Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Platelet-Rich Plasma Injection Market Size
8.1.1 China Platelet-Rich Plasma Injection Sales (2018-2029)
8.1.2 China Platelet-Rich Plasma Injection Revenue (2018-2029)
8.2 China Platelet-Rich Plasma Injection Market Size by Application
8.2.1 China Platelet-Rich Plasma Injection Sales by Application (2018-2029)
8.2.2 China Platelet-Rich Plasma Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Platelet-Rich Plasma Injection Market Size by Type
9.1.1 Asia Platelet-Rich Plasma Injection Sales by Type (2018-2029)
9.1.2 Asia Platelet-Rich Plasma Injection Revenue by Type (2018-2029)
9.2 Asia Platelet-Rich Plasma Injection Market Size by Application
9.2.1 Asia Platelet-Rich Plasma Injection Sales by Application (2018-2029)
9.2.2 Asia Platelet-Rich Plasma Injection Revenue by Application (2018-2029)
9.3 Asia Platelet-Rich Plasma Injection Sales by Region
9.3.1 Asia Platelet-Rich Plasma Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Platelet-Rich Plasma Injection Revenue by Region (2018-2029)
9.3.3 Asia Platelet-Rich Plasma Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Seikagaku Corporation
11.1.1 Seikagaku Corporation Company Information
11.1.2 Seikagaku Corporation Overview
11.1.3 Seikagaku Corporation Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Seikagaku Corporation Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Seikagaku Corporation Recent Developments
11.2 Zimmer Biomet Holdings
11.2.1 Zimmer Biomet Holdings Company Information
11.2.2 Zimmer Biomet Holdings Overview
11.2.3 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zimmer Biomet Holdings Recent Developments
11.3 Orlin & Cohen
11.3.1 Orlin & Cohen Company Information
11.3.2 Orlin & Cohen Overview
11.3.3 Orlin & Cohen Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Orlin & Cohen Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Orlin & Cohen Recent Developments
11.4 Dr. Reddy's Laboratories
11.4.1 Dr. Reddy's Laboratories Company Information
11.4.2 Dr. Reddy's Laboratories Overview
11.4.3 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dr. Reddy's Laboratories Recent Developments
11.5 Chugai Pharmaceutical
11.5.1 Chugai Pharmaceutical Company Information
11.5.2 Chugai Pharmaceutical Overview
11.5.3 Chugai Pharmaceutical Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Chugai Pharmaceutical Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chugai Pharmaceutical Recent Developments
11.6 Flexion Therapeutics
11.6.1 Flexion Therapeutics Company Information
11.6.2 Flexion Therapeutics Overview
11.6.3 Flexion Therapeutics Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Flexion Therapeutics Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Flexion Therapeutics Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Relievus
11.8.1 Relievus Company Information
11.8.2 Relievus Overview
11.8.3 Relievus Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Relievus Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Relievus Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Wright Medical Group
11.10.1 Wright Medical Group Company Information
11.10.2 Wright Medical Group Overview
11.10.3 Wright Medical Group Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Wright Medical Group Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Wright Medical Group Recent Developments
11.11 Anika Therapeutics
11.11.1 Anika Therapeutics Company Information
11.11.2 Anika Therapeutics Overview
11.11.3 Anika Therapeutics Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Anika Therapeutics Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Anika Therapeutics Recent Developments
11.12 Bioventus
11.12.1 Bioventus Company Information
11.12.2 Bioventus Overview
11.12.3 Bioventus Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Bioventus Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bioventus Recent Developments
11.13 Ferring Pharmaceuticals
11.13.1 Ferring Pharmaceuticals Company Information
11.13.2 Ferring Pharmaceuticals Overview
11.13.3 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ferring Pharmaceuticals Recent Developments
11.14 Pfizer
11.14.1 Pfizer Company Information
11.14.2 Pfizer Overview
11.14.3 Pfizer Platelet-Rich Plasma Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Pfizer Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Platelet-Rich Plasma Injection Industry Chain Analysis
12.2 Platelet-Rich Plasma Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Platelet-Rich Plasma Injection Production Mode & Process
12.4 Platelet-Rich Plasma Injection Sales and Marketing
12.4.1 Platelet-Rich Plasma Injection Sales Channels
12.4.2 Platelet-Rich Plasma Injection Distributors
12.5 Platelet-Rich Plasma Injection Customers
13 Market Dynamics
13.1 Platelet-Rich Plasma Injection Industry Trends
13.2 Platelet-Rich Plasma Injection Market Drivers
13.3 Platelet-Rich Plasma Injection Market Challenges
13.4 Platelet-Rich Plasma Injection Market Restraints
14 Key Findings in The Global Platelet-Rich Plasma Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Platelet-Rich Plasma Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Leukocyte-rich (LR)-PRP
Table 3. Major Manufacturers of Leukocyte-poor (LP)-PRP
Table 4. Major Manufacturers of Others
Table 5. Global Platelet-Rich Plasma Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Platelet-Rich Plasma Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Platelet-Rich Plasma Injection Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Platelet-Rich Plasma Injection Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Platelet-Rich Plasma Injection Revenue Market Share by Region (2018-2024)
Table 10. Global Platelet-Rich Plasma Injection Revenue Market Share by Region (2024-2029)
Table 11. Global Platelet-Rich Plasma Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Platelet-Rich Plasma Injection Sales by Region (2018-2024) & (K Units)
Table 13. Global Platelet-Rich Plasma Injection Sales by Region (2024-2029) & (K Units)
Table 14. Global Platelet-Rich Plasma Injection Sales Market Share by Region (2018-2024)
Table 15. Global Platelet-Rich Plasma Injection Sales Market Share by Region (2024-2029)
Table 16. Global Platelet-Rich Plasma Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Platelet-Rich Plasma Injection Sales Share by Manufacturers (2018-2024)
Table 18. Global Platelet-Rich Plasma Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Platelet-Rich Plasma Injection Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Platelet-Rich Plasma Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Platelet-Rich Plasma Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Platelet-Rich Plasma Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Platelet-Rich Plasma Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet-Rich Plasma Injection as of 2022)
Table 24. Global Key Manufacturers of Platelet-Rich Plasma Injection, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Platelet-Rich Plasma Injection, Product Offered and Application
Table 26. Global Key Manufacturers of Platelet-Rich Plasma Injection, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 29. Global Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 30. Global Platelet-Rich Plasma Injection Sales Share by Type (2018-2024)
Table 31. Global Platelet-Rich Plasma Injection Sales Share by Type (2024-2029)
Table 32. Global Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Platelet-Rich Plasma Injection Revenue Share by Type (2018-2024)
Table 35. Global Platelet-Rich Plasma Injection Revenue Share by Type (2024-2029)
Table 36. Platelet-Rich Plasma Injection Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Platelet-Rich Plasma Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 39. Global Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 40. Global Platelet-Rich Plasma Injection Sales Share by Application (2018-2024)
Table 41. Global Platelet-Rich Plasma Injection Sales Share by Application (2024-2029)
Table 42. Global Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Platelet-Rich Plasma Injection Revenue Share by Application (2018-2024)
Table 45. Global Platelet-Rich Plasma Injection Revenue Share by Application (2024-2029)
Table 46. Platelet-Rich Plasma Injection Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Platelet-Rich Plasma Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Platelet-Rich Plasma Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Platelet-Rich Plasma Injection Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Platelet-Rich Plasma Injection Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Platelet-Rich Plasma Injection Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Platelet-Rich Plasma Injection Sales by Country (2024-2029) & (K Units)
Table 61. Europe Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 62. Europe Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 63. Europe Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 66. Europe Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 67. Europe Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Platelet-Rich Plasma Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Platelet-Rich Plasma Injection Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Platelet-Rich Plasma Injection Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Platelet-Rich Plasma Injection Sales by Country (2018-2024) & (K Units)
Table 73. Europe Platelet-Rich Plasma Injection Sales by Country (2024-2029) & (K Units)
Table 74. China Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 75. China Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 76. China Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 79. China Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 80. China Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 83. Asia Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 84. Asia Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 87. Asia Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 88. Asia Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Platelet-Rich Plasma Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Platelet-Rich Plasma Injection Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Platelet-Rich Plasma Injection Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Platelet-Rich Plasma Injection Sales by Region (2018-2024) & (K Units)
Table 94. Asia Platelet-Rich Plasma Injection Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales by Country (2024-2029) & (K Units)
Table 108. Seikagaku Corporation Company Information
Table 109. Seikagaku Corporation Description and Major Businesses
Table 110. Seikagaku Corporation Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Seikagaku Corporation Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Seikagaku Corporation Recent Developments
Table 113. Zimmer Biomet Holdings Company Information
Table 114. Zimmer Biomet Holdings Description and Major Businesses
Table 115. Zimmer Biomet Holdings Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Zimmer Biomet Holdings Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Zimmer Biomet Holdings Recent Developments
Table 118. Orlin & Cohen Company Information
Table 119. Orlin & Cohen Description and Major Businesses
Table 120. Orlin & Cohen Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Orlin & Cohen Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Orlin & Cohen Recent Developments
Table 123. Dr. Reddy's Laboratories Company Information
Table 124. Dr. Reddy's Laboratories Description and Major Businesses
Table 125. Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Dr. Reddy's Laboratories Recent Developments
Table 128. Chugai Pharmaceutical Company Information
Table 129. Chugai Pharmaceutical Description and Major Businesses
Table 130. Chugai Pharmaceutical Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Chugai Pharmaceutical Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Chugai Pharmaceutical Recent Developments
Table 133. Flexion Therapeutics Company Information
Table 134. Flexion Therapeutics Description and Major Businesses
Table 135. Flexion Therapeutics Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Flexion Therapeutics Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Flexion Therapeutics Recent Developments
Table 138. Sanofi Company Information
Table 139. Sanofi Description and Major Businesses
Table 140. Sanofi Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Sanofi Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sanofi Recent Developments
Table 143. Relievus Company Information
Table 144. Relievus Description and Major Businesses
Table 145. Relievus Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Relievus Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Relievus Recent Developments
Table 148. Teva Pharmaceutical Industries Company Information
Table 149. Teva Pharmaceutical Industries Description and Major Businesses
Table 150. Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Teva Pharmaceutical Industries Recent Developments
Table 153. Wright Medical Group Company Information
Table 154. Wright Medical Group Description and Major Businesses
Table 155. Wright Medical Group Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Wright Medical Group Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Wright Medical Group Recent Developments
Table 158. Anika Therapeutics Company Information
Table 159. Anika Therapeutics Description and Major Businesses
Table 160. Anika Therapeutics Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Anika Therapeutics Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Anika Therapeutics Recent Developments
Table 163. Bioventus Company Information
Table 164. Bioventus Description and Major Businesses
Table 165. Bioventus Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Bioventus Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Bioventus Recent Developments
Table 168. Ferring Pharmaceuticals Company Information
Table 169. Ferring Pharmaceuticals Description and Major Businesses
Table 170. Ferring Pharmaceuticals Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Ferring Pharmaceuticals Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Ferring Pharmaceuticals Recent Developments
Table 173. Pfizer Company Information
Table 174. Pfizer Description and Major Businesses
Table 175. Pfizer Platelet-Rich Plasma Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Pfizer Platelet-Rich Plasma Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Pfizer Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Platelet-Rich Plasma Injection Distributors List
Table 181. Platelet-Rich Plasma Injection Customers List
Table 182. Platelet-Rich Plasma Injection Market Trends
Table 183. Platelet-Rich Plasma Injection Market Drivers
Table 184. Platelet-Rich Plasma Injection Market Challenges
Table 185. Platelet-Rich Plasma Injection Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Platelet-Rich Plasma Injection Product Picture
Figure 2. Global Platelet-Rich Plasma Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Platelet-Rich Plasma Injection Market Share by Type in 2022 & 2029
Figure 4. Leukocyte-rich (LR)-PRP Product Picture
Figure 5. Leukocyte-poor (LP)-PRP Product Picture
Figure 6. Others Product Picture
Figure 7. Global Platelet-Rich Plasma Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Platelet-Rich Plasma Injection Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Pharmacy
Figure 12. Platelet-Rich Plasma Injection Report Years Considered
Figure 13. Global Platelet-Rich Plasma Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Platelet-Rich Plasma Injection Revenue 2018-2029 (US$ Million)
Figure 15. Global Platelet-Rich Plasma Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Platelet-Rich Plasma Injection Revenue Market Share by Region (2018-2029)
Figure 17. Global Platelet-Rich Plasma Injection Sales 2018-2029 ((K Units)
Figure 18. Global Platelet-Rich Plasma Injection Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Platelet-Rich Plasma Injection Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Platelet-Rich Plasma Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Platelet-Rich Plasma Injection Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Platelet-Rich Plasma Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Platelet-Rich Plasma Injection Sales YoY (2018-2029) & (K Units)
Figure 24. China Platelet-Rich Plasma Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Platelet-Rich Plasma Injection Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Platelet-Rich Plasma Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Platelet-Rich Plasma Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Platelet-Rich Plasma Injection in the World: Market Share by Platelet-Rich Plasma Injection Revenue in 2022
Figure 31. Global Platelet-Rich Plasma Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 33. Global Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 34. Global Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 35. Global Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Platelet-Rich Plasma Injection Revenue Share by Country (2018-2029)
Figure 41. US & Canada Platelet-Rich Plasma Injection Sales Share by Country (2018-2029)
Figure 42. U.S. Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 45. Europe Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 46. Europe Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 47. Europe Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 48. Europe Platelet-Rich Plasma Injection Revenue Share by Country (2018-2029)
Figure 49. Europe Platelet-Rich Plasma Injection Sales Share by Country (2018-2029)
Figure 50. Germany Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 51. France Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 55. China Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 56. China Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 57. China Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 58. China Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 59. Asia Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 60. Asia Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 61. Asia Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 62. Asia Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 63. Asia Platelet-Rich Plasma Injection Revenue Share by Region (2018-2029)
Figure 64. Asia Platelet-Rich Plasma Injection Sales Share by Region (2018-2029)
Figure 65. Japan Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 69. India Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Platelet-Rich Plasma Injection Sales Share by Country (2018-2029)
Figure 76. Brazil Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Platelet-Rich Plasma Injection Revenue (2018-2029) & (US$ Million)
Figure 81. Platelet-Rich Plasma Injection Value Chain
Figure 82. Platelet-Rich Plasma Injection Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed